| scholarly article | Q13442814 |
| P50 | author | Matthias Egger | Q19996372 |
| Matthew Patrick Fox | Q37383201 | ||
| Olivia Keiser | Q42215630 | ||
| Morna Cornell | Q42883838 | ||
| Hans W. Prozesky | Q43271782 | ||
| Joël Mossong | Q47816839 | ||
| Andrew Boulle | Q53680127 | ||
| Michael Schomaker | Q56517250 | ||
| Christopher J Hoffmann | Q56520992 | ||
| Robin Wood | Q60590121 | ||
| Rob E Dorrington | Q88140485 | ||
| Janet Giddy | Q88716183 | ||
| Daniela Belen Garone | Q117269830 | ||
| International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration | Q117269831 | ||
| P2093 | author name string | Leigh F Johnson | |
| P2860 | cites work | Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals | Q22242705 |
| The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States | Q22242768 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality | Q28475331 | ||
| Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis | Q28476684 | ||
| Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000-2009. | Q30405699 | ||
| Economic returns to investment in AIDS treatment in low and middle income countries | Q31036894 | ||
| Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. | Q33460434 | ||
| Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States | Q33499962 | ||
| Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa | Q33533887 | ||
| Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review | Q33619740 | ||
| Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. | Q33830775 | ||
| Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis | Q33838306 | ||
| Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review | Q33979497 | ||
| Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy | Q34003391 | ||
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
| Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. | Q34166980 | ||
| Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era. | Q34176854 | ||
| Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection | Q34477711 | ||
| Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors | Q34508220 | ||
| Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies | Q34605871 | ||
| Exposing misclassified HIV/AIDS deaths in South Africa | Q34734661 | ||
| Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy | Q35214949 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa | Q36301925 | ||
| Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. | Q36661756 | ||
| Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. | Q36708737 | ||
| Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe | Q37063081 | ||
| Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. | Q37439827 | ||
| Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies | Q37477423 | ||
| Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results | Q37781803 | ||
| Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review | Q37896165 | ||
| Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 | ||
| Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa | Q39911557 | ||
| Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
| Regression models for relative survival | Q47296894 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia | Q57259701 | ||
| Projected life expectancy of people with HIV according to timing of diagnosis | Q57476832 | ||
| A scandal of invisibility: making everyone count by counting everyone | Q57634242 | ||
| All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population | Q57794046 | ||
| Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring | Q74050374 | ||
| The relative survival rate: a statistical methodology | Q79381486 | ||
| Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy | Q79718322 | ||
| How times have changed: HIV and AIDS in South Africa in 2011 | Q83396227 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | South Africa | Q258 |
| collaboration | Q1145523 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | e1001418 | |
| P577 | publication date | 2013-04-09 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies | |
| P478 | volume | 10 |
| Q38559321 | "When the skies fight": HIV, violence and pathways of precarity in South Africa |
| Q35071503 | 'Deep down in their heart, they wish they could be given some incentives': a qualitative study on the changing roles and relations of care among home-based caregivers in Zambia |
| Q35244510 | 'For a mere cough, men must just chew Conjex, gain strength, and continue working': the provider construction and tuberculosis care-seeking implications in Blantyre, Malawi. |
| Q46141782 | 'When you visit a man you should prepare yourself': male community care worker approaches to working with men living with HIV in Cape Town, South Africa |
| Q50064424 | A Conditional Economic Incentive Fails to Improve Linkage to Care and Antiretroviral Therapy Initiation Among HIV-Positive Adults in Cape Town, South Africa |
| Q34374299 | A South African public-private partnership HIV treatment model: viability and success factors. |
| Q104062983 | A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme |
| Q90423010 | A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa |
| Q62486624 | Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysis |
| Q92121447 | Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa |
| Q52641448 | Adult antiretroviral therapy guidelines 2017. |
| Q35993151 | Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study |
| Q38368637 | Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework |
| Q30486897 | An affordable HIV-1 drug resistance monitoring method for resource limited settings |
| Q52352259 | Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa. |
| Q53687056 | Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012. |
| Q91711355 | Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity |
| Q33783987 | Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa |
| Q92908719 | Assessing rates and contextual predictors of 5-year mortality among HIV-infected and HIV-uninfected individuals following HIV testing in Durban, South Africa |
| Q37692981 | Assessing the Impact of Airborne Outreach to Build Clinical Capacity in Rural Botswana |
| Q30994543 | Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era. |
| Q40045999 | Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross-sectional study in Uganda |
| Q58708707 | Avoidable workload of care for patients living with HIV infection in Abidjan, Côte d'Ivoire: A cross-sectional study |
| Q37659139 | Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa |
| Q92486828 | Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data |
| Q64957456 | Bayesian projection of life expectancy accounting for the HIV/AIDS epidemic. |
| Q33712941 | Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records |
| Q40087308 | Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa |
| Q36228325 | Brief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa |
| Q38125299 | Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review |
| Q40301916 | CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone. |
| Q40129359 | CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana |
| Q64109420 | Cardiovascular risk factors among ART-experienced people with HIV in South Africa |
| Q64100649 | Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice |
| Q33859622 | Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates |
| Q36792622 | Changes in self-reported HIV testing during South Africa's 2010/2011 national testing campaign: gains and shortfalls |
| Q36462119 | Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network |
| Q95274216 | Clinical care & blood pressure control among hypertensive people living with human immune deficiency virus: Prospective cohort study |
| Q41139876 | Cochrane Column |
| Q40665399 | Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa. |
| Q33554294 | Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa |
| Q34355099 | Control, struggle, and emergent masculinities: a qualitative study of men's care-seeking determinants for chronic cough and tuberculosis symptoms in Blantyre, Malawi. |
| Q55494732 | Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less. |
| Q64963053 | Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. |
| Q40668946 | Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa |
| Q35955127 | Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. |
| Q42696900 | Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe |
| Q55005415 | Couple serostatus patterns in sub-Saharan Africa illuminate the relative roles of transmission rates and sexual network characteristics in HIV epidemiology. |
| Q39714514 | Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study |
| Q40394069 | Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist Among HIV-infected Infants and Young Children |
| Q92151655 | Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa |
| Q34672929 | Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention? |
| Q34455423 | Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? |
| Q64246571 | Does the public antiretroviral treatment programme meet patients' needs? A study at four hospitals in eThekwini, KwaZulu-Natal, South Africa |
| Q91581770 | Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study |
| Q35873402 | Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients |
| Q28550445 | Early HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM Populations |
| Q51196202 | Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance. |
| Q43184103 | Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care |
| Q56910449 | Effect of age at initiation of antiretroviral therapy on treatment outcomes; A retrospective cohort study at a large HIV clinic in southwestern Uganda |
| Q89635306 | Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial |
| Q36006645 | Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis |
| Q52604630 | Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV. |
| Q64125003 | Epidemiological profile of individuals diagnosed with HIV: results from the preliminary phase of case-based surveillance in Kenya |
| Q26860642 | Epidemiology of ocular surface squamous neoplasia in Africa |
| Q39077290 | Equity in the national rollout of public AIDS treatment in South Africa 2004-08. |
| Q46461115 | Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study |
| Q41471847 | Estimating trends in life expectancy in HIV-positive individuals |
| Q91967346 | Ethical issues in cluster randomized trials conducted in low- and middle-income countries: an analysis of two case studies |
| Q37433470 | Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study |
| Q56911620 | Expert consensus statement on the science of HIV in the context of criminal law |
| Q30651715 | Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India |
| Q47304804 | Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa |
| Q38256237 | Finding a cure for human immunodeficiency virus-1 infection |
| Q30925594 | From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany |
| Q38169292 | Getting to zero HIV deaths: progress, challenges and ways forward |
| Q41216521 | HIV reservoirs as obstacles and opportunities for an HIV cure |
| Q90625412 | HIV testing services in healthcare facilities in South Africa: a missed opportunity |
| Q89530689 | HIV treatment in Guinea-Bissau: room for improvement and time for new treatment options |
| Q27010874 | HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? |
| Q47911148 | HIV, vascular surgery and cardiovascular outcomes: a South African cohort study |
| Q36097352 | HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects |
| Q37328357 | HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up |
| Q60049592 | Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: A grounded theory study |
| Q45374728 | High prevalence of non-communicable diseases and associated risk factors amongst adults living with HIV in Cambodia |
| Q26801331 | Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries |
| Q36157634 | Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer? |
| Q40043345 | IP-10 Levels as an Accurate Screening Tool to Detect Acute HIV Infection in Resource-Limited Settings. |
| Q99589437 | Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa |
| Q53730842 | Improved life expectancy of people living with HIV: who is left behind? |
| Q37723669 | Improving Health and Reducing Comorbidity Associated with HIV: The Development of TAVIE en santé, a Web-Based Tailored Intervention to Support the Adoption of Health Promoting Behaviors among People Living with HIV. |
| Q30278586 | Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda |
| Q36300731 | Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study |
| Q47655423 | Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation |
| Q100294870 | Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015 |
| Q35071520 | Informed consent for HIV cure research in South Africa: issues to consider |
| Q34006969 | Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review |
| Q56965337 | Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney: Experimental Animal Study |
| Q36365683 | Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment |
| Q64061162 | Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe |
| Q41377430 | Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study |
| Q64903981 | Life expectancy and disparities in survival among HIV-infected people receiving antiretroviral therapy: an observational cohort study in Kathmandu, Nepal. |
| Q38405857 | Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis |
| Q39590922 | Life expectancy trends in adults on antiretroviral treatment in South Africa |
| Q41746090 | Long-term impact of antiretroviral therapy in Africa: current knowledge |
| Q92758583 | Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015 |
| Q89468682 | Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function |
| Q35850330 | Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa |
| Q40057840 | Misdiagnosed HIV infection in pregnant women initiating universal ART in South Africa |
| Q37272787 | Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa |
| Q35027610 | Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV. |
| Q34155253 | Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies |
| Q55546820 | Mortality risk in older people on antiretroviral therapy |
| Q30870461 | Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA). |
| Q58091739 | Musculoskeletal symptoms and non-prescribed treatments are common in an urban African population of people living with HIV |
| Q34282914 | Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome |
| Q58732305 | Neurocognitive and mental health outcomes and association with quality of life among adults living with HIV: a cross-sectional focus on a low-literacy population from coastal Kenya |
| Q33596613 | Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti |
| Q91908988 | Outcomes of patients enrolled in an antiretroviral adherence club with recent viral suppression after experiencing elevated viral loads |
| Q30373717 | Participation dynamics in population-based longitudinal HIV surveillance in rural South Africa |
| Q35037738 | Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234). |
| Q56915651 | Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
| Q52669148 | Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort. |
| Q37591592 | Personalized life expectancy and treatment benefit index of antiretroviral therapy |
| Q40401650 | Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects |
| Q30401018 | Physical Therapy and the Global HIV/AIDS Pandemic |
| Q89613451 | Poor rates of linkage to HIV care and uptake of treatment after home-based HIV testing among newly diagnosed 15-to-49 year-old men and women in a high HIV prevalence setting in South Africa |
| Q36925430 | Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008-2011. |
| Q36816564 | Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection |
| Q33733440 | Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa |
| Q59308808 | Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania |
| Q56910962 | Prevalence, detection, treatment, and control of hypertension in human immunodeficiency virus (HIV)-infected patients attending HIV clinics in the Western Cape Province, South Africa |
| Q63866060 | Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa |
| Q57460874 | Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting |
| Q64983102 | Protein and Glycan Mimicry in HIV Vaccine Design. |
| Q28081865 | Psychological interventions for Common Mental Disorders for People Living With HIV in Low- and Middle-Income Countries: systematic review |
| Q53790440 | Public health blindness towards men in HIV programmes in Africa. |
| Q24186953 | Raltegravir for the treatment of HIV infection in adults and children |
| Q37538638 | Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects |
| Q92048571 | Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa |
| Q90744549 | Reaching the 90-90-90 target: lessons from HIV self-testing |
| Q38656063 | Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment |
| Q36515170 | Recent developments in the effort to cure HIV infection: going beyond N = 1. |
| Q34659903 | Renegotiating intimate relationships with men: how HIV shapes attitudes and experiences of marriage for South African women living with HIV: 'Now in my life, everything I do, looking at my health' |
| Q30249073 | Resourcing resilience: social protection for HIV prevention amongst children and adolescents in Eastern and Southern Africa |
| Q27022927 | Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa |
| Q35111077 | Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa |
| Q27013579 | Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review |
| Q33851741 | Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa |
| Q35829549 | Sexual behaviour of people living with HIV attending a tertiary care government hospital in Kathmandu, Nepal: a cross sectional study |
| Q64112923 | Socio-demographic and clinical determinants of late presentation among patients newly diagnosed with HIV in the Eastern Cape, South Africa |
| Q26749501 | Socio-economic differences in HIV/AIDS mortality in South Africa |
| Q40080550 | Stumbling Blocks at the Clinic: Experiences of Seeking HIV Treatment and Care in South Africa |
| Q59354512 | Success factors for universal access to antiretroviral treatments in South Africa |
| Q38401028 | Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies |
| Q92994981 | Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA) |
| Q38879759 | Sustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014. |
| Q34266259 | Taming HIV-related inflammation with physical activity: a matter of timing |
| Q36096194 | Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis |
| Q58586061 | The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons |
| Q38199989 | The HIV epidemic in Southern Africa - Is an AIDS-free generation possible? |
| Q38919177 | The Importance of the Family: A Longitudinal Study of the Predictors of Depression in HIV Patients in South Africa |
| Q38887465 | The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence |
| Q34802334 | The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa |
| Q35850422 | The Missing Men: HIV Treatment Scale-Up and Life Expectancy in Sub-Saharan Africa |
| Q47289013 | The WHO public health approach to HIV treatment and care: looking back and looking ahead |
| Q34691650 | The cascade of care in the Eastern European country of Georgia |
| Q52656286 | The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. |
| Q47646566 | The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia |
| Q93031813 | The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults |
| Q59807594 | The effect of demand-side financial incentives for increasing linkage into HIV treatment and voluntary medical male circumcision: A systematic review and meta-analysis of randomised controlled trials in low- and middle-income countries |
| Q28300749 | The end of AIDS: HIV infection as a chronic disease |
| Q38281773 | The future role of CD4 cell count for monitoring antiretroviral therapy |
| Q36463979 | Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa |
| Q97517578 | Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa |
| Q38851681 | Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population |
| Q38403923 | Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study |
| Q64357339 | Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region |
| Q36686287 | Tuberculosis in Cape Town: An age-structured transmission model |
| Q41929455 | Twelve-year mortality in adults initiating antiretroviral therapy in South Africa |
| Q30835570 | Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana |
| Q36163670 | Who Should We Target? The Impact of Individual and Family Characteristics on the Expressed Need for Community-Based Treatment Support in HIV Patients in South Africa |
Search more.